Improvement Of Diabetes Management And Outcomes: From Screening To Therapy BOLOGNA

Improvement Of Diabetes Management And Outcomes: From Screening To Therapy
Bologna
Emilia Romagna, BOLOGNA

ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA - - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHEOrganisation/Company: ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA - - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHEResearch Field: Medical sciencesResearcher Profile: Recognised Researcher (R2), Leading Researcher (R4), First Stage Researcher (R1), Established Researcher (R3)Country: ItalyApplication Deadline: 31 Jan 2025 - 23:59 (UTC)Type of Contract: To be definedJob Status: Not ApplicableIs the job funded through the EU Research Framework Programme?

Not funded by a EU programmeIs the Job related to staff position within a Research Infrastructure?

NoOffer DescriptionAutoimmune diabetes is increasing in recent years, with a peak incidence in pediatric age and young adulthood.

Recent data show that autoimmunity and the course of the disease allow us to subclassify different types of diabetes, with completely different onset and clinical evolution.

These aspects have recently been highlighted by the need to perform diabetes antibody screening in at-risk populations (LAW 15 of September 2023, n. 130).

This will open the possibility of performing screening in adult populations at risk, with the identification of a cohort of patients with positive autoimmunity with different degrees of dysglycemia and clinical evolution.

The aim of this study is to analyze the clinical evolution, the most appropriate monitoring regimen, and the response to different therapeutic regimens of patients with positive autoimmunity for diabetes, in all stages of the disease (from stage 1 to full-blown diabetes). Number of offers available: 1Eligibility of fellows:Country/ies of residence: AllNationality/ies: All #J-18808-Ljbffr